Q-Line Biotech IPO Details
| IPO Open Date | May 21, 2026 |
| IPO Close Date | May 25, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹326 to ₹343 Per Share |
| Issue Size | Approx ₹214.48 Crores, 62,53,200 Equity Shares |
| Fresh Issue | Approx ₹214.48 Crores, 62,53,200 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Q-Line Biotech IPO Review & Key Points
- Review: May Apply
Q-Line Biotech IPO Market Lot
The Q-Line Biotech IPO minimum market lot is 800 shares with ₹2,74,400 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 800 | ₹2,74,400 |
| Retail Maximum | 2 | 800 | ₹2,74,400 |
| S-HNI Minimum | 3 | 1200 | ₹4,11,600 |
| S-HNI Maximum | 7 | 2800 | ₹9,60,400 |
| B-HNI Minimum | 8 | 3200 | ₹10,97,600 |
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | 17,81,200 Shares | 28.48% |
| QIB (Ex. Anchor) | 11,88,000 Shares | 19.00% |
| NII Shares Offered | 8,91,600 Shares | 14.26% |
| Retail Shares Offered | 20,79,200 Shares | 33.25% |
Q-Line Biotech IPO Anchor Investors
| Anchor Bidding Date | May 20, 2026 |
| Anchor Investors List | |
| Shares Offered | 17,81,200 Shares |
| Anchor Size | 61.10 Cr. |
| lock-in period end date 50% shares (30 Days) | June 22, 2026 |
| lock-in period end date 50% shares (90 Days) | Aug 20, 2026 |
Q-Line Biotech IPO Dates
The Q-Line Biotech IPO date is May 21, and the close date is May 25. The Q-Line Biotech IPO allotment will be finalized on May 26, and the IPO listing on May 29.
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 29, 2026 |
| IPO Bidding Cut-off Time: | May 25, 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,70,74,999 | 96.77% |
| Promoter Holding Post Issue | 2,33,28,199 | -% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
| To meet Working Capital requirements | ₹110.00 |
| Repayment of certain borrowing availed by the Company, in part or full | ₹90.00 |
| General Corporate Purpose | ₹- |
About Q-Line Biotech IPO
Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range.
Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.
Q-Line Biotech IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹184.81 | ₹154.97 | ₹32.10 | ₹251.58 |
| 2024 | ₹206.45 | ₹175.85 | ₹34.44 | ₹339.25 |
| 2025 | ₹322.58 | ₹261.43 | ₹28.13 | ₹455.49 |
| Dec 2025 | ₹236.50 | ₹186.96 | ₹38.69 | ₹561.34 |
Q-Line Biotech IPO Valuation – FY2025
Check Q-Line Biotech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 17.66% |
| ROCE: | 23.74% |
| EBITDA Margin: | 22.73% |
| PAT Margin: | 8.97% |
| Debt to equity ratio: | 0.87 |
| Earning Per Share (EPS): | ₹28.63 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 23.74% |
| Net Asset Value (NAV): | ₹120.60 |
Peer Group Comparison
There are no listed companies in India.
IPO Lead Managers aka Merchant Bankers
- Hem Securities Ltd.
- Share India Capital Services Pvt. Ltd.
Company Address
Q-Line Biotech Ltd.
298-281,
Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Phone: +91 522-2435570
Email: [email protected]
Website: https://qlinebiotech.com/
IPO Registrar
Purva Sharegistry (India) Pvt.Limited.
Phone: +91-022-23018261/ 23016761
Email: [email protected]
Website: https://www.purvashare.com/investor-service/ipo-query
Q-Line Biotech IPO FAQs
What is Q-Line Biotech IPO?
When Q-Line Biotech IPO will open for subscription?
What is Q-Line Biotech IPO Investors Portion?
How to Apply the Q-Line Biotech IPO?
What is Q-Line Biotech IPO Issue Size?
What is Q-Line Biotech IPO Price Band?
What is Q-Line Biotech IPO Lot Size?
What is the Q-Line Biotech IPO Allotment Date?
What is the Q-Line Biotech IPO Listing Date?
Note: The Q-Line Biotech IPO price band and date are officially announced. The (Q-Line Biotech IPO grey market premium) will be added to the IPO GMP page as it will start).
2 Responses
Who are the major clients of the company?
Which product is most popular of the company..well received in the market
Who are the competitors
They are serving more than 15000 cliens including hospitals, diagnostic laboratories, medical colleges and healthcare institutions. Their most popular products are diagnostic medical equipment, consumables, and test kits.